Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

anthraquinone/cancro

O link é salvo na área de transferência
Página 1 a partir de 40 resultados

Anthraquinone compounds as anti cancer compounds

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The present invention relates to a series of substituted alkylaminoanthraquinones, with nitrogen containing heterocyclic substituents, as well as N-oxides of these compounds. The compounds may be alkylating agents having topoisomerase II inhibiting activities. The N-oxides are prodrugs. Resistance
FIELD OF THE INVENTION The present invention relates to heteroannelated anthraquinone derivatives for inhibiting a proliferation activity of a cancer cell, and more particularly to a series of heteroannelated anthraquinone derivatives and the synthesis method thereof. BACKGROUND OF THE INVENTION In

Heteroannelated anthraquinone derivatives for inhibiting cancers

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION The present invention relates to heteroannelated anthraquinone derivatives and their use in treating cancers, and in particular their use in methods for inducing apoptosis, inhibiting telomerase activity and inhibiting abnormal cellular proliferation in living cells, tissues

Anti-neoplastic 1,4-bis-(substituted aminoalkyl amino)-anthraquinones

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND OF THE INVENTION This invention relates to 1,4-bis-(substituted aminoalkylamino)-anthraquinones, and more particularly to the same as anti-neoplastic agents against animal neoplasms. 1,4-bis-substituted anthraquinones have long been known in the prior art as dyes. For example, U.S. Pat.

Lipsome/anthraquinone drug composition and method

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION The present invention relates to an improved liposome/anthraquinone therapeutic composition having reduced lipid oxidation and free-radical damage, and to methods for preparing and using the composition. REFERENCES Aubel-Sadron, G., et al, Biochemie, 66: 333 (1984). Augustin,

Liposome/anthraquinone drug composition and method

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
1. FIELD OF THE INVENTION The present invention relates to an improved liposome/anthraquinone therapeutic composition having reduced lipid oxidation and free-radical damage, and to methods for preparing and using the composition. 2. REFERENCES Aubel-Sadron, G., et al, Biochemie, 66:333

Metal chelates of 1,4-bis(substituted-amino-5,8-dihydroxy-anthraquinones

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
SUMMARY OF THE INVENTION This invention relates to metal chelates of new organic compounds and, more particularly, is concerned with metal chelates of symmetrical 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones which are represented by the following general formula: ##STR1## wherein Q is a

1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to development of cancer drug, in particular, the development of novel 1,2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof. 2. Description of the Prior Art Telomere A telomere is a

1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to development of cancer drug, especially relates to the development of novel 1,2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof. 2. Description of the Prior Art Telomere A telomere

1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase C

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION The present invention relates to the field of treatments for inflammatory and cardiovascular diseases, and chemotherapeutic agents. More particularly, the present invention relates to novel 1,4-bis-(amino-hydroxylalkylamino)-anthraquinones for inhibiting the enzyme protein

Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase C

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION The present invention relates to the field of treatments for inflammatory and cardiovascular diseases, and chemotherapeutic agents. More particularly, the present invention relates to novel asymmetric 1,4-bis-(amino-hydroxylalkylamino)-anthraquinones for inhibiting the enzyme

Method of treating tumors in warm-blooded animals

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BRIEF SUMMARY OF THE INVENTION This invention relates to novel compositions of matter useful for ameliorating cancer diseases in mammals. More particularly, it relates to therapeutic compositions of matter containing certain symmetrical 1,4-bis(substituted-amino)anthraquinones or the non-toxic

Synthesis and use of anti-tumor drug LQC-Y

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
TECHNICAL FIELD The present invention relates to chemistry and bioscience filed, and specifically relates to LQC-Y general structural formula and the synthesis and the use thereof. It is proved by pharmacological experiments that this kind of compounds have a notable anti-tumor effect. No toxic

1-(Aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BRIEF SUMMARY OF THE INVENTION This invention relates to new organic compounds and, more particularly, is concerned with novel 1-(aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones which may be represented by the following general formula: ##STR1## wherein n is an integer from 2 to 4,

1-(Aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BRIEF SUMMARY OF THE INVENTION This invention relates to new organic compounds and, more particularly, is concerned with novel 1-(aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones which may be represented by the following general formula: ##STR1## wherein Z is hydroxy or monoalkylamino
Junte-se à nossa
página do facebook

O mais completo banco de dados de ervas medicinais apoiado pela ciência

  • Funciona em 55 idiomas
  • Curas herbais apoiadas pela ciência
  • Reconhecimento de ervas por imagem
  • Mapa GPS interativo - marcar ervas no local (em breve)
  • Leia publicações científicas relacionadas à sua pesquisa
  • Pesquise ervas medicinais por seus efeitos
  • Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas

Google Play badgeApp Store badge